Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.02
+2.17 (31.68%)
At close: Mar 9, 2026, 4:00 PM EDT
9.38
+0.36 (3.99%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Cartesian Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 125.14 | 212.61 | 76.91 | 106.44 | 4.74 |
| Short-Term Investments | - | - | - | 28.16 | - |
| Cash & Short-Term Investments | 125.14 | 212.61 | 76.91 | 134.6 | 4.74 |
| Cash Growth | -41.14% | 176.44% | -42.86% | 2742.70% | - |
| Accounts Receivable | 1.12 | 0.87 | 8.85 | 9.76 | 3.13 |
| Other Receivables | - | - | - | - | 0.23 |
| Receivables | 1.12 | 0.87 | 8.85 | 9.76 | 3.35 |
| Prepaid Expenses | 3.02 | 3.14 | 4.97 | 3.49 | 0.05 |
| Restricted Cash | - | - | - | 0.29 | - |
| Total Current Assets | 129.28 | 216.63 | 90.73 | 148.14 | 8.14 |
| Property, Plant & Equipment | 17.79 | 15.45 | 12.18 | 14.41 | 1.5 |
| Long-Term Investments | - | 2 | 2 | 2 | - |
| Goodwill | 48.16 | 48.16 | 48.16 | - | - |
| Other Intangible Assets | 93.9 | 150.6 | 150.6 | - | - |
| Other Long-Term Assets | 7.29 | 2.19 | 1.38 | 1.34 | 0.03 |
| Total Assets | 296.41 | 435.02 | 305.05 | 165.89 | 9.67 |
| Accounts Payable | 1.29 | 0.29 | 3.15 | 0.32 | - |
| Accrued Expenses | 9.5 | 11.29 | 14.61 | 14.08 | 0.79 |
| Current Portion of Long-Term Debt | - | - | - | 8.48 | - |
| Current Portion of Leases | 4.15 | 2.85 | 2.17 | 1.61 | 0.17 |
| Current Unearned Revenue | - | - | 2.31 | 0.59 | 0.12 |
| Other Current Liabilities | - | 8.54 | 45.98 | - | 0.19 |
| Total Current Liabilities | 14.94 | 22.98 | 68.21 | 25.08 | 1.27 |
| Long-Term Debt | - | - | - | 17.79 | - |
| Long-Term Leases | 8.53 | 11.13 | 8.79 | 10.06 | 1.11 |
| Long-Term Unearned Revenue | - | - | 3.54 | - | - |
| Long-Term Deferred Tax Liabilities | 6.95 | 16.14 | 15.85 | - | - |
| Other Long-Term Liabilities | 392.24 | 391.58 | 348.29 | 19.14 | 0.35 |
| Total Liabilities | 422.65 | 441.83 | 444.68 | 72.06 | 2.72 |
| Common Stock | 0 | 0 | 0 | 0.02 | - |
| Additional Paid-In Capital | 700.71 | 689.89 | 179.06 | 493.31 | 6.64 |
| Retained Earnings | -822.37 | -692.07 | -614.65 | -394.94 | -19.61 |
| Comprehensive Income & Other | -4.58 | -4.62 | -4.6 | -4.56 | - |
| Total Common Equity | -126.24 | -6.8 | -440.18 | 93.83 | -12.97 |
| Shareholders' Equity | -126.24 | -6.8 | -139.63 | 93.83 | 6.95 |
| Total Liabilities & Equity | 296.41 | 435.02 | 305.05 | 165.89 | 9.67 |
| Total Debt | 12.68 | 13.98 | 10.96 | 37.93 | 1.28 |
| Net Cash (Debt) | 112.46 | 198.63 | 65.96 | 96.68 | 3.46 |
| Net Cash Growth | -43.38% | 201.15% | -31.78% | 2698.18% | - |
| Net Cash Per Share | 4.33 | 11.44 | 12.76 | 19.88 | 0.91 |
| Filing Date Shares Outstanding | 26.51 | 25.91 | 5.4 | - | 3.81 |
| Total Common Shares Outstanding | 26.01 | 25.77 | 5.4 | - | 3.81 |
| Working Capital | 114.34 | 193.65 | 22.52 | 123.06 | 6.87 |
| Book Value Per Share | -4.85 | -0.26 | -81.55 | - | - |
| Tangible Book Value | -268.3 | -205.57 | -638.95 | 93.83 | -12.97 |
| Tangible Book Value Per Share | -10.31 | -7.98 | -118.38 | - | - |
| Machinery | - | 8.15 | 7.63 | 7.34 | 0.78 |
| Construction In Progress | - | 0.7 | 0.15 | 0.6 | - |
| Leasehold Improvements | - | 3.43 | 0.06 | 0.06 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.